Eclipse cuts staff by a quarter to trim operating costs
This article was originally published in Clinica
Executive Summary
Eclipse Surgical Technologies, which develops lasers for use in cardiac transmyocardial revascularisation (TMR), is to cut its workforce by 37 - some 23% - in an attempt to reduce operating costs. The company also plans to cut some dispensable research projects and curtail bonuses. In total, Eclipse hopes to save more than $3 million annually.